GREGoRi Technology Integration Center (U01 Clinical Trials Optional)
This grant funds a center to develop standards and datasets for integrating new molecular technologies and tools to improve rare disease diagnosis.
Funder: National Institutes of Health
Due Dates (Anticipated): November 2025 | November 2026
Funding Amounts: Estimated total program funding: $3,000,000; 1 award anticipated; duration and ceiling not specified.
Summary: Supports the creation of a center to develop and integrate innovative molecular technologies and analytical approaches for rare disease diagnosis.
Description
This funding opportunity, administered by the National Human Genome Research Institute (NHGRI) at NIH, is a forecasted initiative to establish the GREGoRi Technology Integration Center. The Center will drive innovation in rare disease diagnosis by developing, standardizing, and integrating new molecular tools and analytical methods. A primary deliverable will be a comprehensive, multidimensional dataset to benchmark and advance novel diagnostic strategies. The program aims to accelerate the identification of causal genes and variants underlying rare genetic disorders, and to set best practices for the application of emerging molecular technologies in clinical and research settings.
